Cardiovascular adverse events in modern myeloma therapy – Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)

Cardiovascular disease in patients with multiple myeloma may derive from factors unrelated to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related to the disease (cardiac AL-amyloidosis, hyperviscosity, high-output failure, arteriovenous shunting, anemia, renal...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Haematologica
Main Authors: Bringhen, Sara, Milan, Alberto, Ferri, Claudio, Wäsch, Ralph, Gay, Francesca, Larocca, Alessandra, Salvini, Marco, Terpos, Evangelos, Goldschmidt, Hartmut, Cavo, Michele, Petrucci, Maria Teresa, Ludwig, Heinz, Auner, Holger W., Caers, Jo, Gramatzki, Martin, Boccadoro, Mario, Einsele, Hermann, Sonneveld, Pieter, Engelhardt, Monika
פורמט: Artigo
שפה:Inglês
יצא לאור: Ferrata Storti Foundation 2018
נושאים:
Review Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6119131/
https://ncbi.nlm.nih.gov/pubmed/30049825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.191288
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים